Pages that link to "Q36955392"
Jump to navigation
Jump to search
The following pages link to Tumor-derived lymphangiogenic factors and lymphatic metastasis. (Q36955392):
Displaying 12 items.
- Deciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast Cancer (Q28072448) (← links)
- Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib (Q33563488) (← links)
- Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor. (Q34887726) (← links)
- Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis (Q36300824) (← links)
- b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern (Q36892952) (← links)
- Pazopanib: therapeutic developments (Q37642770) (← links)
- Pazopanib: a multikinase inhibitor with activity in advanced renal cell carcinoma (Q37752357) (← links)
- Targeting the ANGPT-TIE2 pathway in malignancy (Q37774852) (← links)
- Collaborative effects between the TNFα-TNFR1-macrophage axis and the VEGF-C-VEGFR3 signaling in lymphangiogenesis and metastasis (Q39834125) (← links)
- Lymphangiogenesis in non-Hodgkin's lymphoma and its correlation with cyclooxygenase-2 and vascular endothelial growth factor-C. (Q42160346) (← links)
- Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis (Q49884430) (← links)
- Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density, and clinicopathologic characteristics in human non-small cell lung cancer (Q51772676) (← links)